Join
Live feed
·
INSIDERFilingvia Quantisnow
Tango Therapeutics Inc. logo

President, R&D Crystal Adam was granted 47,460 shares and sold $226,300 worth of shares (18,452 units at $12.26), increasing direct ownership by 18% to 187,218 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
TNGX· Tango Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNGX (Tango Therapeutics Inc.) and more on Quantisnow.